DCM
Dupont Capital Management Portfolio holdings
AUM
$931M
1-Year Return
22.7%
This Quarter Return
-17.15%
1 Year Return
+22.7%
3 Year Return
+97.62%
5 Year Return
+195.91%
10 Year Return
+436.48%
AUM
$4.2B
AUM Growth
-$266M
(-5.9%)
Cap. Flow
+$680M
Cap. Flow
% of AUM
16.2%
Top 10 Holdings %
Top 10 Hldgs %
39.36%
Holding
1,458
New
221
Increased
471
Reduced
502
Closed
191
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$367M |
| 2 |
iShares MSCI Canada ETF
EWC
|
+$22.1M |
| 3 |
LM
Legg Mason, Inc.
LM
|
+$18.4M |
| 4 |
Microsoft
MSFT
|
+$17M |
| 5 |
Lockheed Martin
LMT
|
+$16.5M |
Top Sells
| 1 |
RTX Corp
RTX
|
+$15.2M |
| 2 |
Materials Select Sector SPDR Fund
XLB
|
+$8.22M |
| 3 |
Delta Air Lines
DAL
|
+$7.98M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$7.83M |
| 5 |
Cisco
CSCO
|
+$7.34M |
Sector Composition
| 1 | Technology | 13.13% |
| 2 | Financials | 10.28% |
| 3 | Healthcare | 8.82% |
| 4 | Industrials | 8.22% |
| 5 | Consumer Discretionary | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Jefferies Financial Group
JEF
$13.8B
| $306K | 0.01% |
23,382
-24,251
| -51% | -$317K |
|
852
Adtran
ADTN
$837M
| $305K | 0.01% |
39,714
| – | – |
|
853
Pacific Biosciences
PACB
$375M
| $304K | 0.01% |
99,217
-146,999
| -60% | -$450K |
|
854
Qorvo
QRVO
$8.1B
| $304K | 0.01% |
3,771
+1,134
| +43% | +$91.4K |
|
855
Spero Therapeutics
SPRO
$111M
| $302K | 0.01% |
+37,421
| New | +$302K |
|
|
UBA
856
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $301K | 0.01% |
21,367
-14,830
| -41% | -$209K |
|
857
Omnicom Group
OMC
$15B
| $298K | 0.01% |
5,436
+1,634
| +43% | +$89.6K |
|
858
Weyerhaeuser
WY
$18.7B
| $298K | 0.01% |
17,567
+5,278
| +43% | +$89.5K |
|
|
CDK
859
DELISTED
CDK Global, Inc.
CDK
| $298K | 0.01% |
9,071
-3,674
| -29% | -$121K |
|
860
Old Second Bancorp
OSBC
$964M
| $297K | 0.01% |
+42,972
| New | +$297K |
|
861
Sangamo Therapeutics
SGMO
$164M
| $296K | 0.01% |
46,459
| – | – |
|
862
Trupanion
TRUP
$1.87B
| $296K | 0.01% |
+11,371
| New | +$296K |
|
863
Fifth Third Bancorp
FITB
$29.9B
| $295K | 0.01% |
19,885
+5,975
| +43% | +$88.6K |
|
|
GOOD
864
Gladstone Commercial Corp
GOOD
$610M
| $295K | 0.01% |
+20,554
| New | +$295K |
|
865
AGCO
AGCO
$8.09B
| $294K | 0.01% |
6,231
-1,837
| -23% | -$86.7K |
|
866
Enova International
ENVA
$2.91B
| $292K | 0.01% |
20,121
-1,928
| -9% | -$28K |
|
867
Ziff Davis
ZD
$1.54B
| $292K | 0.01% |
4,485
-16,432
| -79% | -$1.07M |
|
|
KSU
868
DELISTED
Kansas City Southern
KSU
| $292K | 0.01% |
2,299
-108
| -4% | -$13.7K |
|
869
Maximus
MMS
$5.06B
| $290K | 0.01% |
4,989
-28,110
| -85% | -$1.63M |
|
|
RETA
870
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $290K | 0.01% |
2,012
+276
| +16% | +$39.8K |
|
871
Ameriprise Financial
AMP
$47B
| $289K | 0.01% |
2,818
-15,720
| -85% | -$1.61M |
|
872
Loews
L
$20.2B
| $289K | 0.01% |
8,303
+2,495
| +43% | +$86.8K |
|
873
Artisan Partners
APAM
$3.33B
| $288K | 0.01% |
13,424
| – | – |
|
|
BRT
874
BRT Apartments
BRT
$296M
| $288K | 0.01% |
+28,092
| New | +$288K |
|
875
National Vision
EYE
$1.82B
| $287K | 0.01% |
14,795
+2,029
| +16% | +$39.4K |
|